Abbott eyes intravascular lithotripsy market with clinical trial approval
The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s coronary intravascular…
News
Corscience’s Nasa spacesuit collaboration nears completion
Alcon signs merger agreement to acquire Lensar
Glooko integrates Abbott’s FreeStyle Libre onto platform
UKHSA unveils high-risk pathogen list to drive innovation
Pearsanta acquires patents for adductomics-based DNA damage detection
FDA grants 510(k) clearance for Huntleigh’s CTG Analysis
23andMe’s declining journey ends with bankruptcy filing
